Examining the Differential Effects of Traditional Float-REST and Dry Float on Subjective and Objective Health Outcomes

May 5, 2023 updated by: Victor Finomore, West Virginia University
The objective of this research study is to assess how the implementation of various modern strategies for augmented recovery affect sleep quality, subjective wellness and other indices of general well-being.

Study Overview

Status

Enrolling by invitation

Conditions

Detailed Description

Traditional flotation therapy (Float-REST; Flotation Restricted Environmental Stimulation Therapy) uses sensory deprivation tanks that consist of a very large warm water enclosure with a high concentration of Epsom salt to create a completely buoyant environment. This, along with a combination of temperature that is kept equal to skin temperature (94 degrees), allows the participant to eliminate the gravitational effects on the body, and along with lack of sound and low to no light (depending on comfort) allows the brain and body to completely relax for augmented physical and mental recovery. Provided the growing understanding that sleep quality and quantity are at the forefront of ensuring optimal human performance states, compounded by the deleterious effects of high stress and anxiety on sleep, utilizing flotation therapy as a mechanism for enhancing sleep requires further investigation. In addition to the traditional Float- REST, there have been developments in newer technologies that enhance the convenience of receiving these proposed benefits; Zerobody Dry Float technology (www.Zerobody.com) rids the need for multiple showers by its user, frequent water treatments, and extensive maintenance experienced with traditional flotation environments. However, research is still needed to assess how this recovery modality compares to traditional Float-REST.

To assess whether traditional (Float-REST) or simulated (Dry Float) flotation therapy positively influences sleep and perceptual recovery, participants will undergo a crossover study. Over the course of 9 weeks, participants will alternate Float-REST and Dry Float in 3 week segments with a 1 week break in-between to gather baseline data (known as the testing battery). In addition, testing battery data will be collected at weeks 1 and 9. The order in which participants begin their crossover study, either Float-REST or Dry Float, will be randomly assigned. All participants may wear a fitness tracker and a sleep monitoring ring worn on the finger for the duration of the study. In addition, daily, per session, and pre/post-study questionnaires will be submitted via a smartphone application.

Study Type

Interventional

Enrollment (Anticipated)

100

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Locations

    • West Virginia
      • Morgantown, West Virginia, United States, 26505
        • Rockefeller Neuroscience Institute at West Virginia University

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

16 years to 58 years (Adult)

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria:

• Male or female 18-60 years of age

Exclusion Criteria:

  • Weighs more than 250 pounds
  • Taller than 76 inches
  • Has undergone a float-REST session of any kind in the last 3 months
  • Has a fresh piercings that is less than 6 weeks old from scheduled session
  • Has a fresh tattoo that is less than 4 weeks old from scheduled float
  • Has an injury requiring an orthopedic cast (i.e. plaster or synthetic), immovable splint or brace
  • Is claustrophobic (fear of confined spaces)
  • Has a skin or respiratory sensitivity or allergy to chlorine, sulfate, magnesium, rubber latex or synthetic latex
  • Has a history of or is prone to motion sickness
  • Has had an episode of loss of consciousness in the last 6-months
  • Has had a concussion or traumatic brain injury in the last 6-months
  • Has a contagious skin conditions
  • Has skin ulcers, open rashes, incisions, stitches or large open wounds that could cause pain when exposed to saltwater
  • Has a diagnosis of kidney disease, heart disease or other chronic illness
  • Has a irremovable medical port or catheter
  • Has had a seizure in the last 10 years
  • Has communicable diseases (e.g. HIV, Hepatitis A, B & C, tuberculosis, or measles)
  • Lack of control of bodily functions prior to scheduled float
  • Has a diagnosis of any psychiatric condition (e.g. schizophrenia or bipolar disorder)
  • Pregnant or actively trying to become pregnant

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Basic Science
  • Allocation: Randomized
  • Interventional Model: Crossover Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Active Comparator: Traditional Float-REST Therapy
Participants will utilize sensory deprivation tanks.
Traditional Float-REST therapy uses sensory deprivation tanks that consist of a very large warm water enclosure with a high concentration of Epsom salt to create a completely buoyant environment. This, along with a combination of temperature that is kept equal to skin temperature (94 degrees), allows the participant to eliminate the gravitational effects on the body, and along with lack of sound and low to no light (depending on comfort) allows the brain and body to completely relax for augmented physical and mental recovery. The room will contain an intercom that allows participants to communicate with study personnel in the event they need assistance. Participants will undergo 60 minute sessions twice a week for 3 weeks as one of the two interventions.
Other Names:
  • Sensory Deprivation Tanks
Experimental: Simulated Flotation Therapy
Participants will utilize the Zerobody dry flotation therapy.
The Zerobody is a new technology designed to simulate the effects of traditional Float-REST therapy, but without the contact with salt water. The system has a very thin membrane that cradles the body and provides a warm sensation, similar to that experienced in a traditional flotation tank. The system will be housed in a room that allows for significant reductions in light and sound to mimic the experience of a flotation tank. The room will contain an intercom that allows participants to communicate with study personnel in the event they need assistance. Participants will undergo 60 minute sessions twice a week for 3 weeks using the Zerobody, also termed "dry floating," as one of the two interventions.
Other Names:
  • Zerobody Dry Float

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change in sleep patterns as measured by OURA ring
Time Frame: Daily from baseline through study completion at 9 weeks
Oura Ring is a connected health device worn on the finger that measures sleep. Sleep summaries per day will be compared.
Daily from baseline through study completion at 9 weeks
Change in daily self-report measures for recovery
Time Frame: Daily from baseline through study completion at 9 weeks
Short Recovery and Stress Scale (SRSS)-An 8 item inventory that assess subjective measures of physical, mental, and emotional recovery on a 7 point Likert Scale (0=does not apply at all to 6=fully applies). High values in overall recovery indicate feeling physically and mentally recovered. High values in overall stress indicate feeling overloaded and physically tired. This questionnaire addresses subjective measure of readiness for the day ahead.
Daily from baseline through study completion at 9 weeks
Change in daily self-report measures for task load
Time Frame: Daily from baseline through study completion at 9 weeks
End of Day Questionnaire (EoD)-Developed at the Rockefeller Neuroscience Institute (RNI) as a modification of the NASA Task Load Index. There are 5 Likert scales to assess workload (0=very low and 100=very high), as well as 4 follow up questions. This questionnaire addresses subjective measures of workload and stressors that were encountered throughout the day.
Daily from baseline through study completion at 9 weeks
Change in daily self-report measures in perceived exertion
Time Frame: Daily from baseline through study completion at 9 weeks
Post-Training Rating of Perceived Exertion Questionnaire (Post-Training RPE)- An adaption of the Borg Rating of Perceived Exertion scale, commonly referred to as RPE. The questionnaire requires participants to list the specific activity and the subjective measure of exercise intensity. The scale ranges from 6-20 (6=no exertion that is equivalent to rest and 20=maximal exertion). This questionnaire logs activity (i.e. workout, walk, run, hike) and address subjective exertion levels encountered exercise based activities throughout the day.
Daily from baseline through study completion at 9 weeks
Change in per session self-report measures
Time Frame: 2 times a week, in 3 week increments, through study completion at 9 weeks
State-Trait Anxiety Index (STAI) - Commonly used measure of state and trait anxiety, and done with 20 very brief questions. Values range from 20 to 80, with higher scores representing more severe anxiety. Participants will complete the STAI questionnaire before and after each session, twice a week. The sessions will take place during weeks 2-4 and weeks 6-8.
2 times a week, in 3 week increments, through study completion at 9 weeks
Change in testing battery self-report measures in personality
Time Frame: Week 1, week 5, and week 9
Big Five Inventory (BFI)-44 item inventory designed to measure the Big Five Factors of personality on a 5-point Likert Scale. Higher scores indicate a higher tendency for that personality trait (1=disagree strongly to 5=agree strongly).
Week 1, week 5, and week 9
Change in testing battery self-report measures in emotional regulation
Time Frame: Week 1, week 5, and week 9
Emotion Regulation Questionnaire (ERQ)-10-item scale designed to measure tendency to regulate emotions. Each item is answered on a 7-point Likert Scale (1=strongly disagree to 7=strongly agree). Higher scores indicate a higher emotion regulation strategy.
Week 1, week 5, and week 9
Change in testing battery self-report measures in mindfulness
Time Frame: Week 1, week 5, and week 9
Five Facet Mindfulness Questionnaire (FFMQ)-39 item inventory assesses the five facets of mindfulness on a 5-point Likert Scale (1=never or very rarely true and 5=very often or always true). Each facet is tallied and the sum total responses are divided by 39 (number of items). Higher scores indicate higher levels of mindfulness.
Week 1, week 5, and week 9
Change in testing battery self-report measures in sleep quality
Time Frame: Week 1, week 5, and week 9
Pittsburgh Sleep Quality Index (PSQI)- 19 item inventory with 7 subjective components that assess sleep quality over time. Each component is scored from 0 to 3 (0=very good and 3=very bad). The sum of the components is the global score and ranges 0-21 (0=no difficulty and 21=severe difficulties). The higher the global score, the poorer the sleep quality.
Week 1, week 5, and week 9
Change in testing battery self-report measures for recovery
Time Frame: Week 1, week 5, and week 9

Acute Recovery and Stress Scale (ARSS)- A 32 item inventory that assess subjective measures of physical, mental, and emotional recovery on a 7 point Likert Scale (0=does not apply at all to 6=fully applies). High values in overall recovery indicate feeling physically and mentally recovered. High values in overall stress indicate feeling overloaded and physically tired.

State-Trait Anxiety Index (STAI)-20 item inventory assesses state and trait anxiety. Values range from 20 to 80, with higher scores representing more severe anxiety.

Week 1, week 5, and week 9
Change in testing battery self-report measures for anxiety
Time Frame: Week 1, week 5, and week 9
State-Trait Anxiety Index (STAI)-20 item inventory assesses state and trait anxiety. Values range from 20 to 80, with higher scores representing more severe anxiety.
Week 1, week 5, and week 9
Change in qEEG assessment measures
Time Frame: Week 1, week 5, and week 9

The following assessments are used to determine central nervous system function and overall brain health:

Symptom checklist-150 brief questions; ranking your propensity for traits on 1-7 scale.

qEEG/ERP assessment-determine central nervous system functional integrity and overall brain health. First half of the assessment will consist of recording two segments in both the eyes-closed and eyes-open condition. Next segment is completed in a series of three sequential measurements, of a bilateral pair of EEG channels. Finally, a 10-minute active auditory task.

Week 1, week 5, and week 9
Change in qEEG questionnaire measures for stress
Time Frame: Week 1, week 5, and week 9
Holmes & Rahe Life Stress Inventory- measures amount of stress an individual has experienced within the past year. This scale serves as a control variable; the endorsed events are influencing the individual's current mood, emotions, etc. and in turn their brain function. 43 brief, yes-or-no-type questions.
Week 1, week 5, and week 9
Change in qEEG questionnaire measures
Time Frame: Week 1, week 5, and week 9
PERMA-Profiler-measures five pillars: positive emotion, engagement, relationships, meaning, and accomplishment. The measure consists of 23 items rated on an 11-point Likert scale (0= never/not at all; 10= always/completely.
Week 1, week 5, and week 9

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

July 1, 2020

Primary Completion (Actual)

April 17, 2022

Study Completion (Anticipated)

June 30, 2025

Study Registration Dates

First Submitted

September 24, 2020

First Submitted That Met QC Criteria

November 9, 2020

First Posted (Actual)

November 16, 2020

Study Record Updates

Last Update Posted (Actual)

May 8, 2023

Last Update Submitted That Met QC Criteria

May 5, 2023

Last Verified

May 1, 2023

More Information

Terms related to this study

Other Study ID Numbers

  • 2006024602

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Sleep Quality

Clinical Trials on Traditional Float-REST Therapy

3
Subscribe